Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 29, 2007

PPTI to Aid University of Arizona in Regenerative Medicine Work

  • Protein Polymer Technologies (PPTI) will provide genetically engineered protein polymers to the University of Arizona Department of Aerospace and Mechanical Engineering, according to a materials transfer agreement.

    The University of Arizona plans to design, fabricate, and test the properties of protein-based biomaterials and scaffolds for applications in tissue engineering and regenerative medicine using PPTI's protein polymers.

    Under the agreement, PPTI will have the first option to negotiate a worldwide, exclusive or nonexclusive, royalty-bearing license agreement to the University's inventions or joint inventions enabled by the use of PPTI's protein polymers.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »